The International Myeloma Foundation Says FDA Approval of Kyprolis Gives Patients a Critical New Option
17:25 EDT 20 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
The International Myeloma Foundation (IMF) – the oldest and largest
foundation dedicated to improving the life and care of myeloma patients
– says today’s Food and Drug Administration approval of Onyx’s Kyprolis
(carfilz...
Other Sources for this Article
Planet Communications
Deanne Eagle, 917-837-5866
More From BioPortfolio on "The International Myeloma Foundation Says FDA Approval of Kyprolis Gives Patients a Critical New Option"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
